RGDEF yields 400000.00% · PFE yields 6.20%● Live data
📍 RGDEF pulled ahead of the other in Year 1
Combined, RGDEF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RGDEF + PFE for your $10,000?
RDX Technologies Corporation operates as an energy services and water treatment company in Canada and the United States. It operates through Environmental and Reclamation, Energy, Water, and Equipment Sales and Rentals segments. The Environmental and Reclamation segment engages in the acquisition and liquidation of distressed biofuel and water treatment facilities, including engineering consulting services and the disposal of excess real property and equipment. The Energy segment produces refined fuel. The Water segment offers waste water treatment and related services. The Equipment Sales and Rentals manufacture and sale of components and systems, comprising the sale and rental of complete waste water treatment systems. RDX Technologies Corporation manufactures waste treatment systems, including No Pump interceptor / grease trap system and Sans Tanker fluid transportation systems for water contaminants and the mining of contaminates. The company was formerly known as Ridgeline Energy Services Inc. and changed its name to RDX Technologies Corporation in August 2013. RDX Technologies Corporation is headquartered in Scottsdale, Arizona. On December 5, 2017, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Arizona.
Full RGDEF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.